Open
Source verified March 24, 2026
Accelerate Program for Quebec Emerging Companies
Support for Therapeutics, Med-Tech and Digital Health innovators
Funding available
Varies by project
Deadline
Open continuously
Opened August 20, 2021
Location
Quebec, Canada
Who can apply
Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.
See full eligibility
Overview
Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- No objectives are currently available
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Quebec
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Eligibility
Who is eligible?
Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.Eligible expenses
adMare provides opportunities for collaborations that transform academic research into new therapeutic products and bio-innovation companies. The eligible projects focus on early-stage technology development and company-building in the life sciences sector.
- Collaboration with researchers to translate leading academic research into therapeutics and health innovations.
- Identification and advancement of pre-clinical technologies addressing unmet medical needs.
- Creation of new Canadian life sciences companies by partnering with scientists and entrepreneurs.
- Development of a business case to attract private sector investment.
- Support for growth of existing life sciences companies through shared expertise and investment capital.
Selection criteria
The evaluation and selection criteria for projects under this grant focus on ensuring alignment with adMare's strategic investment goals.
- Differentiation and competitive advantage of the technology.
- Market opportunity and potential for growth.
- Quality and experience of the team involved.
- Scope and strength of intellectual property coverage.
- Potential return on investment.
- The impact of an adMare seed investment in building the company to a value inflection point that attracts private capital.
How to apply
- Step 1: Identify opportunities
- Implications: Assess potential therapeutic opportunities discovered by Canadian researchers that have commercial potential.
- Step 2: Develop & advance technologies
- Implications: Collaborate with founding researchers to progress the discovery towards the next development milestone and investment readiness. Dedicate professional R&D resources and infrastructure to generate valuable data and IP.
- Step 3: Build partnerships
- Implications: Engage partners from academia, industry, patient foundations, the investment community, and key opinion leaders to support the advancement of technologies and creation of new companies.
- Step 4: Assemble a team
- Implications: Work with co-founders to build an experienced management and scientific team to create a compelling business case for investors.
- Step 5: Secure seed investment
- Implications: Evaluate the differentiation, market opportunity, team quality, IP coverage, and potential ROI to secure adMare seed investment that will make the company attractive to private capital.
Contacts
Frequently Asked Questions about the Accelerate Program for Quebec Emerging Companies Program
What is the Accelerate Program for Quebec Emerging Companies?
Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.
Who is eligible for the Accelerate Program for Quebec Emerging Companies program?
To be eligible for the Accelerate Program for Quebec Emerging Companies program, you must:
The applicant must be an emerging company based in Quebec.
The company must demonstrate innovation in their field.
The application should include a detailed business plan.
Who can I contact for more information about the Accelerate Program for Quebec Emerging Companies?
You can contact adMare Bioinnovations or by phone at 514.375.3334.
Where is the Accelerate Program for Quebec Emerging Companies available?
The Accelerate Program for Quebec Emerging Companies program is available the province of Quebec.
Is the Accelerate Program for Quebec Emerging Companies a grant, loan, or tax credit?
Accelerate Program for Quebec Emerging Companies is a Expert Advice
Who are the financial supporters of the Accelerate Program for Quebec Emerging Companies?
Accelerate Program for Quebec Emerging Companies is funded by adMare Bioinnovations